AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr | ₹2,845 Cr | ₹2,365 Cr |
What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹1,928 Cr |
Mar2023 | ₹2,648 Cr |
Mar2022 | ₹5,335 Cr |
Mar2021 | ₹2,845 Cr |
Mar2020 | ₹2,365 Cr |
How is Consolidated Net Profit of AUROBINDO PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,928 Cr | -27.21 | |
Mar2023 | ₹2,648 Cr | -50.36 | |
Mar2022 | ₹5,335 Cr | 87.51 | |
Mar2021 | ₹2,845 Cr | 20.32 | |
Mar2020 | ₹2,365 Cr | - |
Compare Consolidated Net Profit of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹67,294.4 Cr | 0.1% | 9.5% | 4.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 0.1% |
9.5% |
4.2% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses